FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk acute myeloid leukemia and myelodysplastic syndromes

被引：3
|
作者：
Montesinos, Pau [1 ]
de la Rubia, Javier [1 ]
Orti, Guillermo [1 ]
Sanz, Jaime [1 ]
Martinez, David [1 ]
Mendoza, Ninotchka [2 ]
Scaff, Miguel [1 ]
Paciello, Mariliz [1 ]
Romero, Monica [1 ]
Martin, Guillermo [1 ]
Lorenzo, Ignacio [1 ]
Martinez, Jesus [1 ]
Algarra, Lorenzo [1 ]
Jarque, Isidro [1 ]
Perez-Sirvent, Mariluz [1 ]
Sanz, Guillermo [1 ]
Sanz, Miguel A. [1 ]
机构：
[1] Hosp Univ La Fe, Valencia, Spain
[2] CSS Arnulfo Arias Madrid, Panama City, Panama
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.2866.2866
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2866
引用
收藏
页码：843A / 843A
页数：1
相关论文
共 50 条
  • [41] Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high-risk myelodysplastic syndrome
    Shadman, Mazyar
    Mawad, Raya
    Dean, Carol
    Chen, Tara L.
    Shannon-Dorcy, Kathleen
    Sandhu, Vicky
    Hendrie, Paul C.
    Scott, Bart L.
    Walter, Rol B.
    Becker, Pamela S.
    Pagel, John M.
    Estey, Elihu H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 483 - 486
  • [42] Twice Daily Fludarabine and Cytarabine Combination Is Effective in Patients with Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndromes, and Blast Phase Chronic Myeloid Leukemia
    Daver, Naval
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Plunkett, William
    Gandhi, Varsha
    Faderl, Stefan
    O'Brien, Susan
    Borthakur, Gautam
    Kadia, Tapan
    Burger, Jan A.
    Konopleva, Marina
    Brandt, Mark
    Huang, Xuelin
    Jabbour, Elias
    BLOOD, 2011, 118 (21) : 1550 - 1550
  • [43] Fludarabine, cytarabine and G-CSF (FLAG) for the treatment of acute myeloid leukemia (AML) relapsing from autologous bone marrow transplantation (A-BMT).
    Ferrara, F
    Melillo, L
    Montillo, M
    Leoni, F
    Pinto, A
    Mele, G
    Mirto, S
    BLOOD, 1998, 92 (10) : 656A - 656A
  • [44] Idarubicin, Cytarabine and Pravastatin As Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
    Shadman, Mazyar
    Mawad, Raya
    Dean, Carol
    Shannon-Dorcy, Kathleen
    Sandhu, Vicky
    Hendrie, Paul C.
    Scott, Bart L.
    Walter, Roland B.
    Becker, Pamela S.
    Pagel, John
    Estey, Elihu H.
    BLOOD, 2014, 124 (21)
  • [45] A phase II study with decitabine, low-dose cytarabine and G-CSF priming in high-risk myelodysplastic syndromes, refractory/relapsed acute myelogenous leukemia or acute myeloid leukemia in patients with significant comorbidities
    Butera, J.
    Winer, E.
    Wang, C.
    Castillo, J. J.
    Thomas, A. G.
    Safran, H.
    Mega, A. E.
    Colvin, G. A.
    Rathore, B.
    Quesenberry, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study
    Tang, Man Wai
    van der Tuin, Deborah
    Aydin, Mesire
    Heijmans, Jarom
    van de Loosdrecht, Arjan A.
    Meijer, Ellen
    Rutten, Caroline E.
    Wondergem, Marielle
    Janssen, Jeroen J. W. M.
    Donker, Marjolein
    Hazenberg, Mette D.
    Zweegman, Sonja
    Biemond, Bart J.
    de Leeuw, David C.
    Nur, Erfan
    BLOOD, 2022, 140 : 3287 - 3289
  • [47] Treatment of chronic myeloid leukemia in the blastic phase with fludarabine, cytosine arabinoside and G-CSF (FLAG)
    Tedeschi, A
    Montillo, M
    Ferrara, F
    Nosari, A
    Mele, G
    Copia, C
    Leoni, P
    Morra, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (03) : 182 - 187
  • [48] FLAG (Fludarabine, Cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: In vitro and in vivo effects
    Visani, G
    Tosi, P
    Zinzani, PL
    Manfroi, S
    Ottaviani, E
    Cenacchi, A
    Carrara, P
    Clavio, M
    Gobbi, M
    Tura, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 56 (05) : 308 - 312
  • [49] De novo acute myeloid leukemia with multilineage dysplasia:: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG)
    Ferrara, F
    Palmieri, S
    Pocali, B
    Pollio, F
    Viola, A
    Annunziata, S
    Sebastio, L
    Schiavone, EM
    Mele, G
    Gianfaldoni, G
    Leoni, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (04) : 203 - 209
  • [50] A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes
    Invernizzi, R
    Pecci, A
    Iannone, AM
    DAlessio, A
    Giusto, M
    Rossi, G
    Dezza, L
    Ascari, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 864 - 864
12345